摘要:
Novel 2-(3-trifluoromethylanilino)-benzoic acid compounds of the formula
wherein X is
or a valence bond, and R is hydrogen or lower alkyl having from one to four carbon atoms have antiphlogistic properties and are substantially free of undesirable side effects.
摘要:
OR A LOWER ALKYL GROUP HAVING UP TO THREE CARBON ATOMS IN WHICH ONE OR TWO HYDROGEN ATOMS ARE REPLACED BY HYDROXYL GROUPS, ACYLOXY GROUPS HAVING UP TO FOUR CARBON ATOMS, OR LOWER HYDROXYALKOXY GROUPS, HAVING AN ANTIFLAMMATORY ACTION.
and salts thereof with physiologically acceptable acids, in which R1, R2, R5 and R6 represent hydrogen atoms, straight-chain or branched-chain alkyl groups with up to 4 carbon atoms, cycloalkyl, aralkyl, aryl groups or the radicals R1 and R2, and/or radicals R5 and R6, when taken together with the adjacent nitrogen atom represent heterocyclic compounds with 3 to 7 ring members of which 1 to 3 can be hetero atoms, providing that R1, R2 and R5 and R6 can be the same or different radicals, and also the groups -NR1R2 and -NR5R6 can be the same or different, R4 represents a hydrogen atom or a lower alkyl group with up to 3 carbon atoms, R7 represents a hydrogen atom, a lower alkyl group with up to 3 carbon atoms or an aryl group, Z represents a halogen atom, a lower alkyl or alkoxy group with up to 3 carbon atoms, N REPRESENTS A NUMBER FROM 0 TO 2, AND U represents a straight-chain or branched-chain lower alkylene group with 2 to 5 carbon atoms in which a hydrogen atom can be replaced by a hydroxyl group. These compounds have utility as coronary dilatators.
摘要:
A COMPOSITION COMPRISING (+)-1-BENXYL-3-DIMETHYLAMINO-2-METHYL-1-PHENYLPROPYLPROPIONATE (I) ADMIXED WITH A COMPOUND SELECTED FROM THE GROUP CONSISTING OF 2-CHLORO-9-($ - DINETHYLAMINOPROPYLIDENE)-THIOXANTHENE (II), 2 - CHLORO-9-(3-(N''-B-HYDROXYETHYLPIPRAZINO)-PROPYLIDENE)-THIOXANTHENE (III) AND 2-TRIFLUOROMETHY-9-(3(N''-B-HYDROXYETHYLPIPERAZINO)-PROPLIDENE)-THIOXANTHENE (IV). SPECIFIC COMPOSITIONS ARE THOSE IN WHICH THE WEIGHT RATIOS OF THE COMPONENTS AND IN THE CASE OF I AND II, AND I AND III, FROM 1:1 TO 64:1, AND IN THE CASE OF I AND IV FROM 1:1 TO 200:1. THE COMPOSITIONS MAY BE ADMINISTERED IN DOSAGE UNIT FORM. THE ANALGESIC EFFECT OF I AND II, III OR IV IS MORE THAN ADDITIVE, BUT THE SEDATIVE EFFECT OF II, III OR IV IS NOT SUBSTANTIALLY AFFECTED.
摘要:
and salts thereof with physiologically acceptable acids, in which R1, R2, R5 and R6 represent hydrogen atoms, straight-chain or branched-chain alkyl groups with up to 4 carbon atoms, cycloalkyl, aralkyl, aryl groups or the radicals R1 and R2, and/or radicals R5 and R6, when taken together with the adjacent nitrogen atom represent heterocyclic compounds with 3 to 7 ring members of which 1 to 3 can be hetero atoms, providing that R1, R2 and R5 and R6 can be the same or different radicals, and also the groups -NR1R2 and -NR5R6 can be the same or different, R4 represents a hydrogen atom or a lower alkyl group with up to 3 carbon atoms, R7 represents a hydrogen atom, a lower alkyl group with up to 3 carbon atoms or an aryl group, Z represents a halogen atom, a lower alkyl or alkoxy group with up to 3 carbon atoms, N represents a number from 0 to 2, and U represents a straight-chain or branched-chain lower alkylene group with 2 to 5 carbon atoms in which a hydrogen atom can be replaced by a hydroxyl group. These compounds have utility as coronary dilators. Compounds having the general formula (I)
IN WHICH N IS 0, 1 OR 2 AND R represents a hydroxyl group, a low molecular weight straight chained or branched alkoxy group in which the alkyl radical may have individual hydrogen atoms replaced by hydroxyl groups, an amino group or a low molecular weight straight chained or branched mono- or dialkylamino group in which individual hydrogen atoms of the alkyl groups may be replaced by hydroxyl groups. These compounds have a marked antiinflammatory effect and reduced side effects.